Detalles de la búsqueda
1.
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies.
Diabetes Obes Metab
; 24(9): 1810-1818, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35581905
2.
Combination therapy with pioglitazone/exenatide improves beta-cell function and produces superior glycaemic control compared with basal/bolus insulin in poorly controlled type 2 diabetes: A 3-year follow-up of the Qatar study.
Diabetes Obes Metab
; 22(12): 2287-2294, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32729222
3.
Pioglitazone prevents the increase in plasma ketone concentration associated with dapagliflozin in insulin-treated T2DM patients: Results from the Qatar Study.
Diabetes Obes Metab
; 21(3): 705-709, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30259621
4.
Insulin secretion predicts the response to therapy with exenatide plus pioglitazone, but not to basal/bolus insulin in poorly controlled T2DM patients: Results from the Qatar study.
Diabetes Obes Metab
; 20(4): 1075-1079, 2018 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-29227578
5.
Insulin resistance limits corneal nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.
J Diabetes Investig
; 12(11): 2002-2009, 2021 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-34002953
6.
Painful diabetic neuropathy is associated with increased nerve regeneration in patients with type 2 diabetes undergoing intensive glycemic control.
J Diabetes Investig
; 12(9): 1642-1650, 2021 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-33714226
7.
Effect of treatment with exenatide and pioglitazone or basal-bolus insulin on diabetic neuropathy: a substudy of the Qatar Study.
BMJ Open Diabetes Res Care
; 8(1)2020 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-32576561
8.
Efficacy of Exenatide Plus Pioglitazone Vs Basal/Bolus Insulin in T2DM Patients With Very High HbA1c.
J Clin Endocrinol Metab
; 102(7): 2162-2170, 2017 07 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28324038
9.
Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study.
Diabetes Care
; 40(3): 325-331, 2017 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-28096223
10.
Erratum. Combination Therapy With Exenatide Plus Pioglitazone Versus Basal/Bolus Insulin in Patients With Poorly Controlled Type 2 Diabetes on Sulfonylurea Plus Metformin: The Qatar Study. Diabetes Care 2017;40:325-331.
Diabetes Care
; 40(8): 1134, 2017 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-28615237
Resultados
1 -
10
de 10
1
Próxima >
>>